Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells

被引:38
作者
St-Germain, ME [1 ]
Gagnon, V [1 ]
Mathieu, I [1 ]
Parent, S [1 ]
Asselin, E [1 ]
机构
[1] Univ Quebec, Dept Biol & Chem, Med Biol Sect, Trois Rivieres, PQ G9A 5H7, Canada
关键词
Akt; PTEN; apoptosis; prostaglandins; endometrial cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
In human endometrial cancer, the fourth most common cancer in women, tumor suppressor phosphatase tensin homologue (PTEN) is frequently mutated. In the presence of a mutated PTEN protein, Akt phosphorylation levels are increased leading to the activation of this survival pathway. Numerous studies indicated that COX-2 is inappropriately induced and up-regulated in a number of malignant cancer cells. COX-2 plays an important role in tumor cell biology, taking part actively in angiogenesis particularly via the production of prostaglandin E-2 (PGE(2)). The present study was undertaken to determine the involvement of PI 3-K/Akt pathway in the regulation of COXs expression and PGE(2) synthesis. Three different human endometrial cancer cell lines known to have wild-type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies. Results showed that Akt phosphorylation was high in mutated PTEN cells. RT-PCR studies revealed that Akt1 and Akt2 were the regulated forms whereas Akt3 mRNA was nearly undetectable. COX-2 mRNA expression and protein levels were high in these cells compared to wild-type PTEN cells as demonstrated by RT-PCR and Western analysis respectively. PGE(2) production was higher in mutated-PTEN expressing phospho-Akt and COX-2 compared to wild-type PTEN cells. Inhibition of PI 3-K with Wortmannin and LY294002 blocked Akt phosphorylation and inhibited expression of COX-2 in mutated-PTEN cells. Inhibition of Akt phosphorylation with specific PI 3-K inhibitors and down-regulation of COX-2 increased apoptosis in human endometrial cancer cells. Likewise, transfection of mutated-PTEN cells with a dominant negative Akt vector, resulted in COX-2 down-regulation and activation of apoptosis, as demonstrated by Hoechst nuclear staining. On the opposite, activation of Akt using a constitutively active expression vector, resulted in the up-regulation of COX-2 protein expression. Specific inhibition of COX-2 with NS-398 induced apoptosis in COX-2 expressing human endometrial cancer cells. It is concluded that the PI 3-K/Akt survival pathway is involved in the regulation of COX-2 and PGE(2) synthesis in human endometrial cancer cells.
引用
收藏
页码:1311 / 1324
页数:14
相关论文
共 64 条
[1]
Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line [J].
Arico, S ;
Pattingre, S ;
Bauvy, C ;
Gane, P ;
Barbat, A ;
Codogno, P ;
Ogier-Denis, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) :27613-27621
[2]
X-linked inhibitor of apoptosis protein activates the phosphatidylinositol 3-kinase/Akt pathway in rat granulosa cells during follicular development [J].
Asselin, E ;
Wang, YF ;
Tsang, BK .
ENDOCRINOLOGY, 2001, 142 (06) :2451-2457
[3]
Asselin E, 2001, CANCER RES, V61, P1862
[4]
A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION [J].
BELLACOSA, A ;
TESTA, JR ;
STAAL, SP ;
TSICHLIS, PN .
SCIENCE, 1991, 254 (5029) :274-277
[5]
Expression of cyclooxygenase-1 and-2 in urinary bladder carcinoma in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cells [J].
Boström, PJ ;
Aaltonen, V ;
Söderstrom, KO ;
Uotila, P ;
Laato, M .
PATHOLOGY, 2001, 33 (04) :469-474
[6]
MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL PUTATIVE PROTEIN-SERINE KINASE RELATED TO THE CAMP-DEPENDENT AND PROTEIN-KINASE-C FAMILIES [J].
COFFER, PJ ;
WOODGETT, JR .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 201 (02) :475-481
[7]
Inhibition of cyclooxygenase-2 - An approach to preventing cancer of the upper aerodigestive tract [J].
Dannenberg, AJ ;
Altorki, NK ;
Boyle, JO ;
Lin, DT ;
Subbaramaiah, K .
CANCER PREVENTION: MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS, 2001, 952 :109-115
[8]
Davies MA, 1999, CANCER RES, V59, P2551
[9]
Cyclooxygenase-2: a novel target for cancer chemotherapy? [J].
Dempke, W ;
Rie, C ;
Grothey, A ;
Schmoll, HJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (07) :411-417
[10]
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity [J].
Dijkers, PF ;
Birkenkamp, KU ;
Lam, EWF ;
Thomas, NSB ;
Lammers, JWJ ;
Koenderman, L ;
Coffer, PJ .
JOURNAL OF CELL BIOLOGY, 2002, 156 (03) :531-542